Pharm Exec’s Emerging Pharma Leaders 2018

In this ISSUE

Big Companies Driving FDA Fast Lanes

How Fast are the FDA Fast Lanes?

Does Being an Orphan Speed Up FDA Approval?

Top Story

Pharm Exec's Emerging Pharma Leaders 2018

Pharm Exec's 11th annual list profiles the diverse stories of 10 rising biopharma managers—and how each are changing the ways leaders direct critical industry functions
… /Read more/

View the Emerging Pharma Leaders 2018 slideshow

Seeking new ways to engage employees? Check out tips from award-winning recognition provider, Rymax.

Download now

Leadership

Choosing the Right Track: Pharma & Healthcare MBAs

A growing range of MBAs with concentrations in pharmaceuticals and healthcare management are on offer. Pharm Exec look at how three of the top programs in the US prepare their students for industry success
… /Read more/

The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.

Explore now

Regulatory

Are the Right Drugs Getting Faster FDA Approval?

Leela Barham explores expedited FDA approvals with a look at the therapy areas and the overlap with orphan drug designations
… /Read more/

Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.

Learn more

Calendar

/ November 14–15: Commercial Data Insights 2018 /

Philadelphia, PA

/ November 14–15: 5^th Annual Global Compliance Congress for Life Sciences /

London, UK

/ November 28–29: Compliant Patient Support Programs Summit /

Chicago, IL

/ December 3–4: Digital Therapeutics /

New York, NY

/ December 4–5: Bio/Pharma Compliance Congress on Non-Promotional Activities /

Philadelphia, PA

/ December 4–5: Managed Markets Compliance Congress 2018 /

Philadelphia, PA

/ December 12: Specialty Product Data Strategies /

Philadelphia, PA

/ January 22–23, 2019: 14^th Biosimilars Summit /

Alexandria, VA

/ January 23–24, 2019: Data Analytics and Decisions /

Philadelphia, PA

Global

Vienna's Vision on Health Regulation in Europe

What will come out of Austria's shakeup of European pharma rules? Reflector reports
… /Read More/

Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels
Wednesday, October 31, 2018 at 1pm EDT | 12pm CDT | 10am PDT

Global

Targeting the Affluent: Differential Access to Targeted Therapies in China

Disparities in income levels in China continue to drive far-reaching differences in how poorer and richer cancer patients are treated, with recent data suggesting different outcomes for poorer patients. Pieter De Richter reports.
… /Read More/

Audio

Pharm Exec Podcast: Data's Influence on the C-Suite

In this episode, one of this year's Pharm Exec Emerging Pharma Leaders, Pfizer's Christopher Boone, discusses what peaked his interest in public health and data, what challenges pharma faces with data, and where he got his infamous twitter handle!
… /Click here to listen/

Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
Tuesday, October 23, 2018 at 6pm EDT

Industry update

// Rhythm Pharmaceuticals (Boston, MA) appointed Murray W. Stewart, D.M., F.R.C.P., as Chief Medical Officer. // NuLife Sciences (Newport Beach, CA) announced it has appointed Louis J. Resweber as Chairman of the Board, President & Chief Executive Officer. // Marina Biotech (Research Triangle Park, NC) appointed Nancy R. Phelan to serve as a member of its Board of Directors. // Wen Bo Wang, Ph.D. joined Fate Therapeutics (San Diego, CA) as Senior Vice President, Technical Operations. // ContraVir Pharmaceuticals (Edison, NJ) announced the appointment of Robert Foster, Pharm.D., Ph.D. as acting Chief Executive Officer. Dr. Foster succeeds James Sapirstein. // Tom Duley joined Sidley Austin LLP's San Francisco, CA office as partner in its global Life Sciences division. // Emerald Health Therapeutics (Victoria, BC) announced the promotion of Paul R. Dillman, Jr. to Executive Vice President of Global Sales and Marketing. // Vasomune Therapeutics (Toronto, ON) announced Douglas A. Hamilton was appointed President and Chief Executive Officer. Mr. Hamilton will also join Vasomune's Board of Directors.

A panel discussion with insights from emerging biopharma executives
On Demand

Learn More

advertise with us / print subscribe / digital subscribe / visit pharmexec.com